CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top player positioning

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Increase in prevalence of cancer and other chronic disorders
3.3.1.2. Rapid growth in geriatric population
3.3.1.3. Rise in public awareness for disease screening

3.3.2. Restraints

3.3.2.1. Limitations of histopathology
3.3.2.2. Shortage of pathologists in the UK

3.3.3. Opportunity

3.3.3.1. Increase in demand for personalized medicine

CHAPTER 4: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Surgical specimen

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Gastrointestinal biopsy

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Breast biopsy

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

4.5. Lung biopsy

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast

4.6. Biopsy for gynecological cancers

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast

4.7. Renal biopsy

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast

4.8. Pancreatic biopsy

4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast

4.9. Skin tissue biopsy

4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast

4.10. Liver biopsy

4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast

4.11. Nerve biopsy

4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast

4.12. Testicular biopsy

4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast

4.13. Others

4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast

CHAPTER 5: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY

5.1. Overview

5.1.1. Market size and forecast

5.2. Germany

5.2.1. Market size and forecast

5.3. France

5.3.1. Market size and forecast

5.4. UK

5.4.1. Market size and forecast

5.5. Italy

5.5.1. Market size and forecast

5.6. Spain

5.6.1. Market size and forecast

5.7. Rest of Europe

5.7.1. Market size and forecast

CHAPTER 6: COMPANY PROFILES

6.1. Acculabs Diagnostics UK Ltd.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segment

6.2. Cellular Pathology Services Limited

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments

6.3. Great Ormond Street Hospital (GOSH) Laboratory

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments

6.4. HCA Laboratories UK

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segment

6.5. Laboratoire Cerba

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments

6.6. Sonic Healthcare Limited

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance

6.7. Spire Healthcare Group Plc

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. Targos Molecular Pathology GmbH

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments

6.9. TPL Path Labs

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments

6.10. Unilabs Group Services

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Key strategic moves and developments